Skip to main content

Books in Drug discovery

Elsevier's Drug Delivery collection is an indispensable resource for scientists and researchers in the pharmaceutical field, exploring the administration of pharmaceutical compounds for therapeutic effects from molecule identification to medication development. It provides comprehensive coverage, including crucial aspects such as drug screening, medicinal chemistry, and preclinical safety assessments.

11-20 of 69 results in All results

Chemoinformatics and Bioinformatics in the Pharmaceutical Sciences

  • 1st Edition
  • May 21, 2021
  • Navneet Sharma + 3 more
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 2 1 7 4 8 - 1
  • eBook
    9 7 8 - 0 - 1 2 - 8 2 1 7 4 7 - 4
Chemoinformatics and Bioinformatics in the Pharmaceutical Sciences brings together two very important fields in pharmaceutical sciences that have been mostly seen as diverging from each other: chemoinformatics and bioinformatics. As developing drugs is an expensive and lengthy process, technology can improve the cost, efficiency and speed at which new drugs can be discovered and tested. This book presents some of the growing advancements of technology in the field of drug development and how the computational approaches explained here can reduce the financial and experimental burden of the drug discovery process. This book will be useful to pharmaceutical science researchers and students who need basic knowledge of computational techniques relevant to their projects. Bioscientists, bioinformaticians, computational scientists, and other stakeholders from industry and academia will also find this book helpful.

The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry

  • 1st Edition
  • April 23, 2021
  • Stephanie K. Ashenden
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 2 0 0 4 5 - 2
  • eBook
    9 7 8 - 0 - 1 2 - 8 2 0 4 4 9 - 8
The Era of Artificial Intelligence, Machine Learning and Data Science in the Pharmaceutical Industry examines the drug discovery process, assessing how new technologies have improved effectiveness. Artificial intelligence and machine learning are considered the future for a wide range of disciplines and industries, including the pharmaceutical industry. In an environment where producing a single approved drug costs millions and takes many years of rigorous testing prior to its approval, reducing costs and time is of high interest. This book follows the journey that a drug company takes when producing a therapeutic, from the very beginning to ultimately benefitting a patient’s life. This comprehensive resource will be useful to those working in the pharmaceutical industry, but will also be of interest to anyone doing research in chemical biology, computational chemistry, medicinal chemistry and bioinformatics.

Multifunctional Theranostic Nanomedicines in Cancer

  • 1st Edition
  • March 16, 2021
  • Malay K. Das
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 2 1 7 1 2 - 2
  • eBook
    9 7 8 - 0 - 1 2 - 8 2 1 7 0 0 - 9
Multifunctional Theranostic Nanomedicines in Cancer focuses on new trends, applications, and the significance of novel multifunctional nanotheranostics in cancer imaging for diagnosis and treatment. Cancer nanotechnology offers new opportunities for cancer diagnosis and treatment. Multifunctional nanoparticles harboring various functions—including targeting, imaging, and therapy—have been intensively studied with the goal of overcoming the limitations of conventional cancer diagnosis and therapy. Thus theranostic nanomedicines have emerged in recent years to provide an efficient and safer alternative in cancer management. This book covers polymer-based therapies, lipid-based therapies, inorganic particle-based therapies, photo-related therapies, radiotherapies, chemotherapies, and surgeries. Multifunctional Theranostic Nanomedicines in Cancer offers an indispensable guide for researchers in academia, industry, and clinical settings; it is also ideal for postgraduate students; and formulation scientists working on cancer.

Preparation of Phytopharmaceuticals for the Management of Disorders

  • 1st Edition
  • November 3, 2020
  • Chukwuebuka Egbuna + 2 more
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 2 0 2 8 4 - 5
  • eBook
    9 7 8 - 0 - 1 2 - 8 2 0 2 8 5 - 2
Preparation of Phytopharmaceuticals for the Management of Disorders: The Development of Nutraceuticals and Traditional Medicine presents comprehensive coverage and recent advances surrounding phytopharmaceuticals, nutraceuticals and traditional and alternative systems of medicines. Sections cover the concepts of phytopharmaceuticals, their history, and current highlights in phytomedicine. Also included are classifications of crude drugs, herbal remedies and toxicity, traditional and alternative systems of medicine, nanotechnology applications, and herbal cosmeticology. Final sections cover applications of microbiology and biotechnology in drug discovery. This book provides key information for everyone interested in drug discovery, including medicinal chemists, nutritionists, biochemists, toxicologists, drug developers and health care professionals. Students, professors and researchers working in the area of pharmaceutical sciences and beyond will also find the book useful.

Drug Discovery Targeting Drug-Resistant Bacteria

  • 1st Edition
  • May 15, 2020
  • Prashant Kesharwani + 2 more
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 1 8 4 8 0 - 6
  • eBook
    9 7 8 - 0 - 1 2 - 8 1 8 4 8 1 - 3
Drug Discovery Targeting Drug-Resistant Bacteria explores the status and possible future of developments in fighting drug-resistant bacteria. The book covers the majority of microbial diseases and the drugs targeting them. In addition, it discusses the potential targeting strategies and innovative approaches to address drug resistance. It brings together academic and industrial experts working on discovering and developing drugs targeting drug-resistant (DR) bacterial pathogens. New drugs active against drug-resistant pathogens are discussed, along with new strategies being used to discover molecules acting via new modes of action. In addition, alternative therapies such as peptides and phages are included. Pharmaceutical scientists, microbiologists, medical professionals, pathologists, researchers in the field of drug discovery, infectious diseases and microbial drug discovery both in academia and in industrial settings will find this book helpful.

Combination Therapy Against Multidrug Resistance

  • 1st Edition
  • April 30, 2020
  • Mohmmad Younus Wani + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 2 0 5 7 6 - 1
  • eBook
    9 7 8 - 0 - 1 2 - 8 2 0 5 7 8 - 5
Combination Therapy against Multidrug Resistance explores the potential of combination therapy as an efficient strategy to combat multi-drug resistance. Multidrug resistance (MDR) occurs when microorganisms such as bacteria, fungi, viruses, and parasites are excessively exposed to antimicrobial drugs such as antibiotics, antifungals, or antivirals, and in response the microorganism undergoes mutations or develops different resistance mechanisms to combat the drug for its survival. MDR is becoming an increasingly serious problem in both developed and developing nations. Bacterial resistance to antibiotics has developed faster than the production of new antibiotics, making bacterial infections increasingly difficult to treat, and the same is true for a variety of other diseases. Combination therapy proves to be a promising strategy as it offers potential benefits such as a broad spectrum of efficacy, greater potency than the drugs used in monotherapy, improved safety and tolerability, and reduction in the number of resistant organisms. This book considers how combination therapy can be applied in multiple situations, including cancer, HIV, tuberculosis, fungal infections, and more. Combination Therapy Against Multidrug Resistance gathers the most relevant information on the prospects of combination therapy as a strategy to combat multridrug resistance and helping to motivate the industrial sector and government agencies to invest more in research and development of this strategy as a weapon to tackle the multidrug resistance problem. It will be useful to academics and researchers involved in the development of new antimicrobial or antiinfective agents and treatment strtategies to combat multidrug resistance. Clinicians and medical nurses working in the field of infection prevention and control (IPC) will also find the book relevant

Cancer-Leading Proteases

  • 1st Edition
  • January 9, 2020
  • Satya Prakash Gupta
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 1 8 1 6 8 - 3
  • eBook
    9 7 8 - 0 - 1 2 - 8 1 8 1 6 9 - 0
Cancer-Leading Proteases: Structures, Functions, and Inhibition presents a detailed discussion on the role of proteases as drug targets and how they have been utilized to develop anticancer drugs. Proteases possess outstanding diversity in their functions. Because of their unique properties, proteases are a major focus of attention for the pharmaceutical industry as potential drug targets or as diagnostic and prognostic biomarkers. This book covers the structure and functions of proteases and the chemical and biological rationale of drug design relating to how these proteases can be exploited to find useful chemotherapeutics to fight cancers. In addition, the book encompasses the experimental and theoretical aspects of anticancer drug design based on proteases. It is a useful resource for pharmaceutical scientists, medicinal chemists, biochemists, microbiologists, and cancer researchers working on proteases.

Basic Fundamentals of Drug Delivery

  • 1st Edition
  • November 30, 2018
  • Rakesh Kumar Tekade
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 1 7 9 0 9 - 3
  • eBook
    9 7 8 - 0 - 1 2 - 8 1 7 9 1 0 - 9
Basic Fundamentals of Drug Delivery covers the fundamental principles, advanced methodologies and technologies employed by pharmaceutical scientists, researchers and pharmaceutical industries to transform a drug candidate or new chemical entity into a final administrable drug delivery system. The book also covers various approaches involved in optimizing the therapeutic performance of a biomolecule while designing its appropriate advanced formulation.

Validamycin and Its Derivatives

  • 1st Edition
  • March 31, 2017
  • Xiaolong Chen + 3 more
  • English
  • Paperback
    9 7 8 - 0 - 0 8 - 1 0 0 9 9 9 - 4
  • eBook
    9 7 8 - 0 - 0 8 - 1 0 1 1 1 3 - 3
Validamycin and Its Derivatives: Discovery, Chemical Synthesis and Biological Activity presents, for the first time, a complete review of the underlying chemistry, synthesis, behavior and application of these compounds. Beginning with an introduction to validamycin, the book then outlines the key elements of its discovery and production, including details of its structures, isolation, analysis, and issues relating to its large scale production. Biological activities are then explored in more detail, followed by details of biosynthesis. Further to this, the chemical synthesis of validamycin and its intermediates, including valienamine, validamine, valiolamine, and validoxylamines is reviewed, before preparation of these derivatives and their biological activities are explored. Finally, the book concludes with a discussion of the economic aspects of working with validamycin and its potential in future applications and trends. With its detailed chemical coverage from a team of expert authors, this detailed guide can be applied to the large-scale industrial production of antibiotics and the adaptation of bioactive agents, from agricultural, to novel pharmaceutical applications.

Progress in Medicinal Chemistry

  • 1st Edition
  • Volume 56
  • March 15, 2017
  • David R. Witty + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 4 - 6 3 9 3 9 - 4
  • eBook
    9 7 8 - 0 - 4 4 4 - 6 3 9 4 3 - 1
Progress in Medicinal Chemistry, Volume 56 provides a review of eclectic developments in medicinal chemistry. This volume includes chapters covering recent advances in cancer therapeutics, fluorine in medicinal chemistry, a perspective on the next generation of antibacterial agents derived by manipulation of natural products, a potential new era for Chagas Disease drug discovery, and imaging in drug development. Specific chapters cover timely topics, such as the development of LRRK2 inhibitors for the treatment of Parkinson's, and recent discoveries and developments in TRPA1 modulators. Users will find a comprehensive resource on the topic of medicinal chemistry that also discusses avenues for the acceleration of drug discovery programs.